https://www.euronews.com/next/2023/03/26/leukaemia-breakthrough-pill-revumenib-menin-inhibitor-trial-sees-cancer-vanish-18-patients
0
0
3/26/23 at 10:31am
Organization
Euronews
Author
Imane El Atillah
More than half of the patients enrolled in an early clinical trial responded to the drug. One-third saw their cancer vanish entirely.
Create an account
or login to join the discussion